Galventa
Galventa is a Swiss life science company that develops patented galenic formulations for the nutraceutical and pharmaceutical industries. The company specializes in delivery systems with unique release profiles and clinical validation, exemplified by their flagship brand B · SYNC® which targets the wake-up process. Their technology is designed to improve the pharmacokinetic performance and bioavailability of supplements and plant extracts.
Visit websiteSaint Gallen, Switzerland
Life Sciences
Nutraceuticals
Pharmaceuticals
Biotechnology
Funding summary
- Total raised
- €841K
- Funding rounds
- 2
Investors in Galventa
Investors on record for Galventa. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Galventa?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors